Evidence map›Paper›PMID 37375599›Full record

Trial reportNutrients2023

Effect of a Hop Extract Standardized in 8-Prenylnaringenin on Bone Health and Gut Microbiome in Postmenopausal Women with Osteopenia: A One-Year Randomized, Double-Blind, Placebo-Controlled Trial.

Manon Lecomte, Diego Tomassi, René Rizzoli, Mathieu Tenon, Thierry Berton, Sinead Harney, Pascale Fança-Berthon

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Gut microbiome and bone health: update on mechanisms, clinical correlations, and possible treatment strategies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Pooled it
  2. Pooled it
  3. Bone health: biology and nutrition.Current opinion in clinical nutrition and metabolic care · 2024
    Pooled it
  4. Article
  5. The gut-bone-inflammation axis: intestinal barrier disruption as a central driver of osteoporosis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Biology · 2025
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Manon LecomteGivaudan France Naturals, 84911 Avignon, France.ORCID 0000-0001-7986-8600
Diego TomassiBiofortis, 44800 Saint-Herblain, France.ORCID 0009-0007-6336-2219
René RizzoliService of Bone Disease, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva, Switzerland.
Mathieu TenonGivaudan France Naturals, 84911 Avignon, France.
Thierry BertonGivaudan France Naturals, 84911 Avignon, France.
Sinead HarneyRheumatology Department, Cork University Hospital, T12 DFK4 Cork, Ireland.
Pascale Fança-BerthonGivaudan France Naturals, 84911 Avignon, France.
Givaudan (France) · FRCork University Hospital · IEInstitut Génétique Nantes Atlantique · FRUniversity Hospital of Geneva · CH

Funding

Givaudan France Naturals Private funding
6 · The paper itself

Abstract

Estrogen deficiency increases the risk of osteoporosis and fracture. The aim of this study was to investigate whether a hop extract standardized in 8-prenylnaringenin (8-PN), a potent phytoestrogen, could improve bone status of osteopenic women and to explore the gut microbiome roles in this effect. In this double-blind, placebo-controlled, randomized trial, 100 postmenopausal, osteopenic women were supplemented with calcium and vitamin D3 (CaD) tablets and either a hop extract (HE) standardized in 8-PN (

Indexed as

Bone Diseases, MetabolicGastrointestinal MicrobiomeOsteoporosis, PostmenopausalBone DensityDouble-Blind MethodFemaleFlavanonesHumansPostmenopauseQuality of Life8-prenylnaringeninFlavanones8-PNbonehopmenopausemicrobiomeosteopeniaosteoporosisphytoestrogen

Identifiers

PMID37375599
PMCPMC10304064
OpenAlexW4380080281

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.